Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Directorate Changes

26 Jul 2017 07:00

RNS Number : 0789M
Quartix Holdings PLC
26 July 2017
 

26 July 2017

Quartix Holdings plc

("Quartix" or the "Company")

Directorate changes

Quartix Holdings plc, a leading supplier of subscription-based vehicle tracking systems, software and services in the UK, is pleased to announce the appointment of Ed Ralph as Chief Operating Officer. Ed joined the Company in February this year and yesterday, at a committee meeting of the board to approve the interim results, was appointed to the Board of Quartix Holdings plc.

Ed brings to Quartix extensive experience and a proven track record in technology management, digital marketing and eCommerce. From 2001 to 2015 he built and led the technology team at Abcam plc ("Abcam"), having joined the company as the seventh employee and at a time when its revenues were just £200k. After leaving Abcam Ed served in non-executive or consultancy roles related to technology and marketing at a range of Cambridge-based companies, including Red Gate Software, Axol Bioscience and Congenica. During this time he also conducted consulting projects for Quartix in 2016 before joining the Company full time in February 2017.

Ed has a first-class honours degree in biochemistry from Southampton University, a PhD in molecular biology and biotechnology from Sheffield University and was conducting post-doctoral research at the University of Cambridge prior to joining Abcam.

Commenting on the appointment, Andy Walters, Managing Director of Quartix, said: "Having worked with Ed since last year, I am delighted that he is now joining the Board in this senior executive role. Ed brings proven skills in digital marketing, technology and eCommerce which will be invaluable to Quartix in the next stage of its development."

The Company is also announcing today that, following 10 years of exceptional service to the business, David Bridge, the Company's Finance Director, has indicated that he would like to retire from the business at some point in 2018. David remains committed to the company and will work with the rest of the Board to ensure that an orderly transition is achieved. Plans to recruit a successor for David are already well underway, and a further announcement concerning his appointment will be made in due course.

Andy Walters commented: "I would like to record my personal thanks for the enormous contribution that David has made to the business since he joined as Finance Director in January 2008. He will be greatly missed and we wish him well for the future."

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Managing Director

David Bridge, Finance Director

 

01686 806 663

finnCap (Nominated Adviser and Broker)

Matt Goode/Scott Mathieson (Corporate Finance)

Stephen Norcross/Alice Lane (Corporate Broking)

020 7220 0500

 

Additional information:

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies:

Edward Tatsuya Ralph, aged 42, has been a director of the following companies during the five years preceding the date of this announcement

Current directorships

Past directorships

Quartix Ltd

 

Axol Bioscience Ltd

 

At the date of this announcement, Mr Ralph holds 79,795 ordinary shares in the Company, representing 0.17% of the Company's issued share capital.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEAXXSAEFXEFF
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.